|
Volumn 23, Issue 4, 1996, Pages 873-887
|
Long-term outlook for survivors of congenital diaphragmatic hernia
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
HISTAMINE H2 RECEPTOR ANTAGONIST;
PHENOBARBITAL;
PROKINETIC AGENT;
ANTIREFLUX OPERATION;
CLINICAL PROTOCOL;
CLINICAL TRIAL;
CONGENITAL DIAPHRAGM HERNIA;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
EXTRACORPOREAL OXYGENATION;
FAILURE TO THRIVE;
FEMALE;
FOLLOW UP;
GASTROESOPHAGEAL REFLUX;
HERNIOPLASTY;
HUMAN;
INCIDENCE;
INFANT;
MAJOR CLINICAL STUDY;
MALE;
MEDICAL RECORD;
MORBIDITY;
MUSCLE FLAP;
MUSCULOSKELETAL DISEASE;
PATHOPHYSIOLOGY;
PERCEPTION DEAFNESS;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
SEIZURE;
SURVIVAL;
|
EID: 0030446378
PISSN: 00955108
EISSN: None
Source Type: Journal
DOI: 10.1016/s0095-5108(18)30214-8 Document Type: Review |
Times cited : (127)
|
References (56)
|